WO2002077021A3 - Proteines et acides nucleiques de streptococcus pneumoniae - Google Patents
Proteines et acides nucleiques de streptococcus pneumoniae Download PDFInfo
- Publication number
- WO2002077021A3 WO2002077021A3 PCT/IB2002/002163 IB0202163W WO02077021A3 WO 2002077021 A3 WO2002077021 A3 WO 2002077021A3 IB 0202163 W IB0202163 W IB 0202163W WO 02077021 A3 WO02077021 A3 WO 02077021A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acids
- streptococcus pneumoniae
- pneumoniae proteins
- proteins
- streptocccus
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 241000193998 Streptococcus pneumoniae Species 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02735782A EP1373513A2 (fr) | 2001-03-27 | 2002-03-27 | Proteines et acides nucleiques de streptococcus pneumoniae |
AU2002309130A AU2002309130A1 (en) | 2001-03-27 | 2002-03-27 | Streptococcus pneumoniae proteins and nucleic acids |
US10/472,928 US20050020813A1 (en) | 2001-03-27 | 2002-03-27 | Streptococcus pneumoniae proteins and nucleic acids |
CA002439431A CA2439431A1 (fr) | 2001-03-27 | 2002-03-27 | Proteines et acides nucleiques de streptococcus pneumoniae |
JP2002576279A JP2005503119A (ja) | 2001-03-27 | 2002-03-27 | Streptococcuspneumoniaeタンパク質および核酸 |
US12/897,952 US20120128707A1 (en) | 2001-03-27 | 2010-10-05 | Streptococcus pneumoniae proteins and nucleic acids |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0107658.7 | 2001-03-27 | ||
GBGB0107658.7A GB0107658D0 (en) | 2001-03-27 | 2001-03-27 | Streptococcus pneumoniae |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/897,952 Division US20120128707A1 (en) | 2001-03-27 | 2010-10-05 | Streptococcus pneumoniae proteins and nucleic acids |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002077021A2 WO2002077021A2 (fr) | 2002-10-03 |
WO2002077021A3 true WO2002077021A3 (fr) | 2003-08-28 |
Family
ID=9911673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2002/002163 WO2002077021A2 (fr) | 2001-03-27 | 2002-03-27 | Proteines et acides nucleiques de streptococcus pneumoniae |
Country Status (7)
Country | Link |
---|---|
US (2) | US20050020813A1 (fr) |
EP (9) | EP1373513A2 (fr) |
JP (2) | JP2005503119A (fr) |
AU (1) | AU2002309130A1 (fr) |
CA (1) | CA2439431A1 (fr) |
GB (1) | GB0107658D0 (fr) |
WO (1) | WO2002077021A2 (fr) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6800744B1 (en) | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
SI1141308T1 (sl) | 1998-12-22 | 2007-08-31 | Microscience Ltd | Streptokokni proteini skupine B in njihova uporaba |
US6890539B2 (en) | 1998-12-22 | 2005-05-10 | Microscience, Ltd. | Genes and proteins, and their use |
US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
US7074415B2 (en) | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
EP2189473A3 (fr) | 2000-10-27 | 2010-08-11 | Novartis Vaccines and Diagnostics S.r.l. | Acides nucléiques et protéines dérivés des groupes de streptocoques A et B |
GB0107658D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
CA2444133A1 (fr) * | 2001-04-16 | 2002-10-24 | Wyeth Holdings Corporation | Nouveaux cadres de lecture ouverts de streptococcus pneumoniae codant pour des antigenes polypeptidiques, et leurs utilisations |
EP1456231A2 (fr) * | 2001-12-20 | 2004-09-15 | Shire Biochem Inc. | Antigenes de streptococcus |
EP2275122A3 (fr) * | 2002-04-02 | 2011-05-18 | Ben Gurion University Of The Negev Research And Development Authority | Vaccins contre le streptococcus pneumoniae à base de protéine |
US8691243B2 (en) * | 2002-04-02 | 2014-04-08 | Ben-Gurion University Of The Negev Research And Development Authority | Protein-based Streptococcus pneumoniae vaccine |
GB0208499D0 (en) * | 2002-04-12 | 2002-05-22 | Microscience Ltd | Streptococcal genes |
GB0302218D0 (en) | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
DE60328481D1 (de) * | 2002-05-14 | 2009-09-03 | Novartis Vaccines & Diagnostic | Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält |
AU2003250684A1 (en) * | 2002-07-31 | 2004-02-16 | Affinium Pharmaceuticals, Inc. | Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures |
EP1597348A4 (fr) * | 2002-08-26 | 2010-03-31 | Novartis Vaccines & Diagnostic | Genomes de streptocoques conserves ou specifiques |
FR2846668B1 (fr) * | 2002-11-05 | 2007-12-21 | Univ Aix Marseille Ii | Identification moleculaire des bacteries du genre streptococcus et genres apparentes |
AU2003286056A1 (en) * | 2002-11-26 | 2004-06-18 | Id Biomedical Corporation | Streptococcus pneumoniae surface polypeptides |
SI1601770T1 (sl) | 2003-03-04 | 2010-01-29 | Intercell Ag | Streptococcus pyogenes antigeni |
WO2004092209A2 (fr) * | 2003-04-15 | 2004-10-28 | Intercell Ag | Antigenes s-pneumoniae |
EP1477802A1 (fr) * | 2003-05-16 | 2004-11-17 | Erasmus Universiteit Rotterdam | Procédé de selection et de fabrication des constituents du vaccine, et leur utilisation en vaccines |
WO2005001057A2 (fr) | 2003-06-23 | 2005-01-06 | North Carolina State University | Composes utilisant les acides nucleiques lactobacillus acidophilus codants pour le fructo-oligosaccharide et leurs utilisations |
CA2532369C (fr) | 2003-07-31 | 2016-07-26 | Chiron Corporation | Compositions immunogenes pour streptococcus pyogenes |
GB0318688D0 (en) * | 2003-08-08 | 2003-09-10 | Chiron Srl | Streptococcus pneumoniae knockout mutants |
JP2007529195A (ja) * | 2003-08-15 | 2007-10-25 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インク. | 歯周病の診断,治療,およびモニタリングのためのPorphyromonasgingivalis毒性ポリヌクレオチドの同定 |
AU2004271018B2 (en) * | 2003-09-04 | 2007-10-11 | Ezaki Glico Co., Ltd. | Method of making sucrose phosphorylase(SP) heat-stable |
US8945589B2 (en) * | 2003-09-15 | 2015-02-03 | Novartis Vaccines And Diagnostics, Srl | Immunogenic compositions for Streptococcus agalactiae |
KR20050037283A (ko) * | 2003-10-18 | 2005-04-21 | 송재훈 | 폐렴구균의 필수유전자 또는 그로부터 발현되는 단백질을포함하는 항생물질 스크리닝용 조성물 및 이를 이용하는항생물질 스크리닝 방법 |
BRPI0416376A (pt) * | 2003-11-10 | 2007-03-06 | Uab Research Foundation | composições para a redução da colonização bacteriana e da invasão do snc e métodos de uso destes |
US20060165716A1 (en) | 2004-07-29 | 2006-07-27 | Telford John L | Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
AT500835B1 (de) * | 2004-09-13 | 2007-12-15 | Affiris Forschungs & Entwicklungs Gmbh | Cholinestertransport-protein-mimotop als atherosklerose-medikament |
CA2583803C (fr) * | 2004-10-08 | 2014-11-25 | Giuliano Bensi | Compositions immunogenes et therapeutiques pour streptococcus pyogenes |
GB0428394D0 (en) * | 2004-12-24 | 2005-02-02 | Chiron Srl | Saccharide conjugate vaccines |
WO2006084466A2 (fr) * | 2005-02-11 | 2006-08-17 | Ace Biosciences A/S | Polypeptides de streptococcus pneumoniae situes en surface |
US9931397B2 (en) | 2005-06-27 | 2018-04-03 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
CA2642721A1 (fr) * | 2006-02-17 | 2007-10-18 | Novartis Ag | Purification d'antigenes bacteriens |
US7572457B2 (en) * | 2006-03-31 | 2009-08-11 | Wisconsin Alumni Research Foundation | Use of Streptococcus suis 38 kDa polypeptide as an immunogen |
PL2054431T3 (pl) * | 2006-06-09 | 2012-07-31 | Novartis Ag | Konformery adhezyn bakteryjnych |
EP2081953A2 (fr) * | 2006-08-17 | 2009-07-29 | The UAB Research Foundation | Polypeptides immunogeniques de pcpa e leur utilisations |
EP2094297A2 (fr) * | 2006-10-30 | 2009-09-02 | Novartis AG | Compositions immunogènes et thérapeutiques pour streptococcus pyogènes |
WO2008056759A1 (fr) * | 2006-11-09 | 2008-05-15 | Kyowa Hakko Bio Co., Ltd. | Procédé de production de dipeptide |
WO2008119358A2 (fr) * | 2007-03-30 | 2008-10-09 | Ace Biosciences A/S | Polypeptides de streptococcus pneumoniae situés en surface pour une utilisation dans des compositions de vaccin |
EP1980266A1 (fr) * | 2007-04-12 | 2008-10-15 | Radboud University Nijmegen | Nouveaux facteurs de virulence de la pneumonie à streptocoques |
EP2460535A1 (fr) * | 2007-04-12 | 2012-06-06 | Stichting Katholieke Universiteit, more particularly the Radboud University Nijmegen Medical Centre | Nouveaux facteurs de virulence de la pneumonie ?streptocoques |
EP1980267A1 (fr) * | 2007-04-13 | 2008-10-15 | Rijksuniversiteit Groningen | Protéine de transcytosis de pneumonie S |
AU2007353789B2 (en) | 2007-05-23 | 2014-05-22 | The Uab Research Foundation | Detoxified pneumococcal neuraminidase and uses thereof |
US20160228500A9 (en) * | 2007-07-23 | 2016-08-11 | Martina Ochs | Immunogenic Polypeptides and Monoclonal Antibodies |
GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
US8287885B2 (en) | 2007-09-12 | 2012-10-16 | Novartis Ag | GAS57 mutant antigens and GAS57 antibodies |
WO2009081274A2 (fr) | 2007-12-21 | 2009-07-02 | Novartis Ag | Formes mutantes de la streptolysine o |
WO2009115508A2 (fr) * | 2008-03-17 | 2009-09-24 | Intercell Ag | Peptides luttant contre s. pneumoniae et compositions, méthodes et utilisations associées |
EP2108656A1 (fr) * | 2008-03-19 | 2009-10-14 | Beninati, Concetta | Fragments de protéines antigéniques de streptococcus pneumoniae |
EP2174664A1 (fr) * | 2008-10-07 | 2010-04-14 | Stichting Katholieke Universiteit, more particularly the Radboud University Nijmegen Medical Centre | Nouveaux facteurs de virulence de la pneumonie à streptocoques |
EP2356225A1 (fr) | 2008-12-03 | 2011-08-17 | Protea Vaccine Technologies Ltd. | Fragments de glutamyl-arnt-synthétase (gts) |
EP2381953A4 (fr) | 2009-01-06 | 2016-06-29 | C3 Jian Inc | Fragments antimicrobiens ciblés |
WO2011008548A1 (fr) * | 2009-06-29 | 2011-01-20 | Genocea Biosciences, Inc. | Vaccins et compositions contre le streptococcus pneumoniae |
WO2011067758A2 (fr) | 2009-12-02 | 2011-06-09 | Protea Vaccine Technologies Ltd. | Fragments immunogènes et multimères pour protéines de streptococcus pneumoniae |
EP2538971B1 (fr) | 2010-02-23 | 2015-10-28 | Stichting Katholieke Universiteit | Vaccin combiné pour streptococcus |
EP2550289A4 (fr) | 2010-03-12 | 2013-11-27 | Childrens Medical Center | Nouveaux immunogènes et procédés pour la découverte et le dépistage de ceux-ci |
KR101311886B1 (ko) | 2010-05-26 | 2013-09-26 | 한국기초과학지원연구원 | 폐렴연쇄상구균의 분비단백질을 포함하는 폐렴 진단용 조성물 |
RU2623174C2 (ru) * | 2011-01-20 | 2017-06-22 | Дженоцея Байосайенсиз, Инк. | Вакцины и композиции против streptococcus pneumoniae |
EP3912619A1 (fr) | 2011-05-11 | 2021-11-24 | Children's Medical Center Corporation | Protéine de liaison à la biotine modifiée, leurs protéines de fusion et applications |
US20140186386A1 (en) * | 2011-06-06 | 2014-07-03 | Jeffrey Weiser | Methods for preventing and treating staphylococcus aureus colonization, infection, and disease |
CA2897020A1 (fr) | 2012-01-20 | 2013-07-25 | Genocea Biosciences, Inc. | Vaccins et compositions antigeniques fusionnes contre streptococcus pneumoniae |
JP2015510872A (ja) | 2012-03-07 | 2015-04-13 | ノバルティス アーゲー | Streptococcuspneumoniae抗原の増強された製剤 |
AU2013341349A1 (en) * | 2012-11-06 | 2015-05-21 | Medimmune Limited | Combination therapies using anti-Pseudomonas Psl and PcrV binding molecules |
CA2900008A1 (fr) * | 2013-02-07 | 2014-08-14 | Children's Medical Center Corporation | Antigenes de proteine qui conferent une protection contre une colonisation et/ou une maladie pneumococcique |
US10048254B2 (en) | 2013-06-04 | 2018-08-14 | Albany Medical College | Cyclic-di-AMP specific detection |
WO2015082501A1 (fr) | 2013-12-03 | 2015-06-11 | Virometix Ag | Peptides riches en proline protecteurs contre s. pneumoniae |
US9328275B2 (en) | 2014-03-07 | 2016-05-03 | Prc Desoto International, Inc. | Phosphine-catalyzed, michael addition-curable sulfur-containing polymer compositions |
FR3020070B1 (fr) * | 2014-04-22 | 2018-11-02 | Universite Grenoble Alpes | Proteines nadph oxydases |
JP6399589B2 (ja) * | 2014-10-28 | 2018-10-03 | 国立大学法人山口大学 | 肺炎球菌における発現プロモーター |
CN110191893B (zh) * | 2016-11-22 | 2023-03-21 | 武汉华大吉诺因生物科技有限公司 | 多肽及其应用 |
CN110730670A (zh) | 2017-03-28 | 2020-01-24 | 儿童医疗中心有限公司 | 基于多抗原提呈系统(maps)的金黄色葡萄球菌疫苗、免疫原性组合物以及它们的用途 |
WO2018183666A1 (fr) * | 2017-03-31 | 2018-10-04 | Boston Medical Center Corporation | Procédés et compositions utilisant des protéines de surface pneumococciques très conservées |
TW201925222A (zh) | 2017-06-23 | 2019-07-01 | 美商醫院疫苗公司 | 免疫原性組成物 |
CN112969474A (zh) | 2018-09-12 | 2021-06-15 | 艾芬尼维克斯公司 | 多价肺炎球菌疫苗 |
EP3962533A4 (fr) * | 2019-04-30 | 2023-01-25 | The Medical College of Wisconsin, Inc. | Plateforme d'administration au travers du tympan, et utilisation de celle-ci |
WO2023006825A1 (fr) * | 2021-07-29 | 2023-02-02 | Université de Lausanne | Nouveaux antigènes polypeptidiques pneumococciques |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998018931A2 (fr) * | 1996-10-31 | 1998-05-07 | Human Genome Sciences, Inc. | Polynucleotides et sequences de streptococcus pneumoniae |
WO2000006738A2 (fr) * | 1998-07-27 | 2000-02-10 | Microbial Technics Limited | Acides nucleiques et proteines de streptococcus pneumoniae |
Family Cites Families (160)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2386796A (en) | 1942-08-05 | 1945-10-16 | Bond Crown & Cork Co | Extruding device |
DE2855719A1 (de) | 1978-12-22 | 1980-07-10 | Siemens Ag | Zahnaerztliche handstueckanordnung |
US4336336A (en) | 1979-01-12 | 1982-06-22 | President And Fellows Of Harvard College | Fused gene and method of making and using same |
AU545912B2 (en) | 1980-03-10 | 1985-08-08 | Cetus Corporation | Cloned heterologous jive products in bacillies |
ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
NZ199722A (en) | 1981-02-25 | 1985-12-13 | Genentech Inc | Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain |
DK188582A (da) | 1981-04-29 | 1982-10-30 | Biogen Nv | Bacillus-kloningsvektorer rekombinations-dna-molekyler bacillus-vaerter transformeret dermed samt fremgangsmaader til ekspressionaf fremmede dna-sekvenser og fremstilling af polypeptideer som er kodede dermed |
US4551433A (en) | 1981-05-18 | 1985-11-05 | Genentech, Inc. | Microbial hybrid promoters |
US4405712A (en) | 1981-07-01 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | LTR-Vectors |
US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
CA1341302C (fr) | 1983-02-22 | 2001-10-09 | Rae Lyn Burke | Systemes d'expression de la levure avec vecteurs ayant des promoteurs de gapdh ou pyk et synthese de proteine etrangere |
US4876197A (en) | 1983-02-22 | 1989-10-24 | Chiron Corporation | Eukaryotic regulatable transcription |
JPS59166086A (ja) | 1983-03-09 | 1984-09-19 | Teruhiko Beppu | 新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法 |
US4546083A (en) | 1983-04-22 | 1985-10-08 | Stolle Research & Development Corporation | Method and device for cell culture growth |
US4588684A (en) | 1983-04-26 | 1986-05-13 | Chiron Corporation | a-Factor and its processing signals |
JPS59205983A (ja) | 1983-04-28 | 1984-11-21 | ジエネツクス・コ−ポレイシヨン | 異種遺伝子を原核微生物で発現させる方法 |
US4663280A (en) | 1983-05-19 | 1987-05-05 | Public Health Research Institute Of The City Of New York | Expression and secretion vectors and method of constructing vectors |
ATE78293T1 (de) | 1983-05-27 | 1992-08-15 | Texas A & M Univ Sys | Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors. |
US4689406A (en) | 1983-08-10 | 1987-08-25 | Amgen | Enhancement of microbial expression of polypeptides |
US4870008A (en) | 1983-08-12 | 1989-09-26 | Chiron Corporation | Secretory expression in eukaryotes |
JPS6054685A (ja) | 1983-09-02 | 1985-03-29 | Suntory Ltd | 改良発現ベクタ−およびその利用 |
EP0136907A3 (fr) | 1983-10-03 | 1986-12-30 | Genentech, Inc. | Système de contrôle d'expression xenogénésiaque, méthode pour son utilisation, vecteurs d'expression le contenant, cellules transformées par ceux-ci et protéines hétérologues produites par ceux-ci |
WO1995013796A1 (fr) | 1993-11-16 | 1995-05-26 | Depotech Corporation | Vesicules a taux controle de liberation des principes actifs |
DK518384A (da) | 1984-01-31 | 1985-07-01 | Idaho Res Found | Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse |
EP0164556B1 (fr) | 1984-05-11 | 1994-03-02 | Chiron Corporation | Transcription augmentée dans les levures par usage d'une construction hybride de la région du promoteur |
US4880734A (en) | 1984-05-11 | 1989-11-14 | Chiron Corporation | Eukaryotic regulatable transcription |
CA1282721C (fr) | 1984-06-04 | 1991-04-09 | Bernard Roizman | Virus de l'herpes simplex utilise comme vecteur |
US5288641A (en) | 1984-06-04 | 1994-02-22 | Arch Development Corporation | Herpes Simplex virus as a vector |
US4738921A (en) | 1984-09-27 | 1988-04-19 | Eli Lilly And Company | Derivative of the tryptophan operon for expression of fused gene products |
US4745056A (en) | 1984-10-23 | 1988-05-17 | Biotechnica International, Inc. | Streptomyces secretion vector |
US4837148A (en) | 1984-10-30 | 1989-06-06 | Phillips Petroleum Company | Autonomous replication sequences for yeast strains of the genus pichia |
US4762915A (en) | 1985-01-18 | 1988-08-09 | Liposome Technology, Inc. | Protein-liposome conjugates |
US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
EP0196056B1 (fr) | 1985-03-28 | 1991-05-22 | Chiron Corporation | Expression de gènes fusionnés pour la production de protéines |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4865974A (en) | 1985-09-20 | 1989-09-12 | Cetus Corporation | Bacterial methionine N-terminal peptidase |
US4777127A (en) | 1985-09-30 | 1988-10-11 | Labsystems Oy | Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus |
JPS6296086A (ja) | 1985-10-21 | 1987-05-02 | Agency Of Ind Science & Technol | 複合プラスミド |
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
US5091309A (en) | 1986-01-16 | 1992-02-25 | Washington University | Sindbis virus vectors |
US4861719A (en) | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
ATE110111T1 (de) | 1986-05-02 | 1994-09-15 | Gist Brocades Nv | Sekretionssignal-selektionsvektoren für extrazelluläre proteinsynthese in bazillen. |
ATE247708T1 (de) | 1986-10-02 | 2003-09-15 | Massachusetts Inst Technology | Verfahren zur regulierung der metabolischen stabilität von proteinen |
JPS63123383A (ja) | 1986-11-11 | 1988-05-27 | Mitsubishi Kasei Corp | ハイブリツドプロモ−タ−、発現調節dna配列および発現ベクタ− |
GB8702816D0 (en) | 1987-02-07 | 1987-03-11 | Al Sumidaie A M K | Obtaining retrovirus-containing fraction |
US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
DK175243B1 (da) | 1987-03-23 | 2004-07-19 | Zymogenetics Inc | Ekspressionsvektor, der er i stand til at styre ekspression af heterologe gener eller cDNA i gær, gærværtscelle samt fremgangsmåde til öget produktion af proteiner i gærværtsceller |
US4980289A (en) | 1987-04-27 | 1990-12-25 | Wisconsin Alumni Research Foundation | Promoter deficient retroviral vector |
WO1989001973A2 (fr) | 1987-09-02 | 1989-03-09 | Applied Biotechnology, Inc. | Virus variolique recombinant d'immunisation contre des antigenes associes a une tumeur |
DK463887D0 (da) | 1987-09-07 | 1987-09-07 | Novo Industri As | Gaerleader |
EP0378576B1 (fr) | 1987-09-11 | 1995-01-18 | Whitehead Institute For Biomedical Research | Fibroblastes transduits et leurs applications |
US4929555A (en) | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
IE62868B1 (en) | 1987-11-18 | 1995-03-08 | Chiron Corp | Hepatitis C virus |
WO1989005349A1 (fr) | 1987-12-09 | 1989-06-15 | The Australian National University | Procede servant a combattre des infections virales |
CA1340772C (fr) | 1987-12-30 | 1999-09-28 | Patricia Tekamp-Olson | Expression et secretion de proteines heterologues dans une levure au moyen de sequences leader tronquees du facteur alpha |
US4973551A (en) | 1988-01-15 | 1990-11-27 | Merck & Co., Inc. | Vector for the expression of fusion proteins and protein immunogens |
US5591624A (en) | 1988-03-21 | 1997-01-07 | Chiron Viagene, Inc. | Retroviral packaging cell lines |
CH684094A5 (de) | 1988-03-21 | 1994-07-15 | Viagene Inc | Rekombinante Retroviren. |
US5662896A (en) | 1988-03-21 | 1997-09-02 | Chiron Viagene, Inc. | Compositions and methods for cancer immunotherapy |
US5206152A (en) | 1988-04-08 | 1993-04-27 | Arch Development Corporation | Cloning and expression of early growth regulatory protein genes |
US5422120A (en) | 1988-05-30 | 1995-06-06 | Depotech Corporation | Heterovesicular liposomes |
AP129A (en) | 1988-06-03 | 1991-04-17 | Smithkline Biologicals S A | Expression of retrovirus gag protein eukaryotic cells |
EP0432216A1 (fr) | 1988-09-01 | 1991-06-19 | Whitehead Institute For Biomedical Research | Retrovirus de recombinaison a gammes d'hotes amphotropiques et ecotropiques |
DE3841091A1 (de) | 1988-12-07 | 1990-06-13 | Behringwerke Ag | Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung |
US5217879A (en) | 1989-01-12 | 1993-06-08 | Washington University | Infectious Sindbis virus vectors |
DE68907045T2 (de) | 1989-01-17 | 1993-12-02 | Eniricerche Spa | Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind. |
EP0832980B1 (fr) | 1989-01-23 | 2002-06-19 | Chiron Corporation | Thérapie recombinante des infections et désordres hyperprolifératifs |
WO1990009441A1 (fr) | 1989-02-01 | 1990-08-23 | The General Hospital Corporation | Vecteur d'expression du virus d'herpes simplex, type i |
JP3140757B2 (ja) | 1989-02-06 | 2001-03-05 | デイナ・フアーバー・キヤンサー・インステイテユート | パッケージング欠陥hivプロウイルス、細胞系及びその使用 |
HU218717B (hu) | 1989-03-17 | 2000-11-28 | E. I. Du Pont De Nemours And Co. | Nukleinsav-termelést fokozó növényi eredetű génfragmentek és eljárás előállításukra |
DE69032284T2 (de) | 1989-03-21 | 1998-10-08 | Vical Inc | Expression von exogenen polynukleotidsequenzen in wirbeltieren |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
JPH0832638B2 (ja) | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
EP0486573B1 (fr) | 1989-08-15 | 1995-10-11 | Pasminco Australia Limited | Absorption de vapeur de zinc dans du plomb fondu |
EP0487587A1 (fr) | 1989-08-18 | 1992-06-03 | Chiron Corporation | Retrovirus de recombinaison apportant des constructions de vecteur a des cellules cibles |
US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
US5166057A (en) | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
GB8919607D0 (en) | 1989-08-30 | 1989-10-11 | Wellcome Found | Novel entities for cancer therapy |
IT1237764B (it) | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
AU7007491A (en) | 1990-02-02 | 1991-08-08 | Schweiz. Serum- & Impfinstitut Bern | Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses |
ZA911974B (en) | 1990-03-21 | 1994-08-22 | Res Dev Foundation | Heterovesicular liposomes |
CA2039921A1 (fr) | 1990-04-16 | 1991-10-17 | Xandra O. Breakefield | Transfert et expression de la sequence d'adn dans les cellules du systeme nerveux central a l'aide de mutants du virus de l'herpes, avec deletions chez les genes en vue de repliquer le virus |
AU7906691A (en) | 1990-05-23 | 1991-12-10 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Adeno-associated virus (aav)-based eucaryotic vectors |
US5149655A (en) | 1990-06-21 | 1992-09-22 | Agracetus, Inc. | Apparatus for genetic transformation |
DE69113564T2 (de) | 1990-08-13 | 1996-05-30 | American Cyanamid Co | Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff. |
JPH06500923A (ja) | 1990-09-21 | 1994-01-27 | カイロン コーポレイション | パッケージング細胞 |
WO1992007945A1 (fr) | 1990-10-30 | 1992-05-14 | Dana Farber Cancer Institute | Alteration specifique du type cellulaire des niveaux de produits geniques dans des cellules |
US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
SE9003978D0 (sv) | 1990-12-13 | 1990-12-13 | Henrik Garoff | Dna expressionssystem baserade paa ett virus replikon |
CA2098849C (fr) | 1990-12-20 | 2007-07-10 | Ralph R. Weichselbaum | Controle de l'expression de genes par rayonnement ionisant |
DE69233013T2 (de) | 1991-08-20 | 2004-03-04 | The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
FR2681786A1 (fr) | 1991-09-27 | 1993-04-02 | Centre Nat Rech Scient | Vecteurs recombinants d'origine virale, leur procede d'obtention et leur utilisation pour l'expression de polypeptides dans des cellules musculaires. |
IL103059A0 (en) | 1991-09-30 | 1993-02-21 | Boehringer Ingelheim Int | Conjugates for introducing nucleic acid into higher eucaryotic cells |
NZ244306A (en) | 1991-09-30 | 1995-07-26 | Boehringer Ingelheim Int | Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation |
US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
WO1993010218A1 (fr) | 1991-11-14 | 1993-05-27 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Vecteurs comprenant des genes etrangers et des marqueurs selectifs negatifs |
GB9125623D0 (en) | 1991-12-02 | 1992-01-29 | Dynal As | Cell modification |
WO1993014778A1 (fr) | 1992-01-23 | 1993-08-05 | Vical, Inc. | Transfert de genes ex vivo |
IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
FR2688514A1 (fr) | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
JPH07507689A (ja) | 1992-06-08 | 1995-08-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 特定組織のターゲティング方法及び組成物 |
JPH09507741A (ja) | 1992-06-10 | 1997-08-12 | アメリカ合衆国 | ヒト血清による不活性化に耐性のあるベクター粒子 |
GB2269175A (en) | 1992-07-31 | 1994-02-02 | Imperial College | Retroviral vectors |
WO1994008026A1 (fr) | 1992-09-25 | 1994-04-14 | Rhone-Poulenc Rorer S.A. | Vecteurs d'adenovirus pour le transfert de genes etrangers dans des cellules du systeme nerveux central, en particulier du cerveau |
WO1994011506A1 (fr) | 1992-11-18 | 1994-05-26 | Arch Development Corporation | Transfert de genes au moyen d'un adenovirus au muscle lisse cardiaque et vasculaire |
CA2592997A1 (fr) | 1992-12-03 | 1994-06-09 | Genzyme Corporation | Vecteurs pseudo-adenoviraux |
US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
US5348358A (en) | 1993-02-22 | 1994-09-20 | Selick David A | Contact lens insertion tool |
DE4311651A1 (de) | 1993-04-08 | 1994-10-13 | Boehringer Ingelheim Int | Virus für den Transport von Fremd-DNA in höhere eukaryotische Zellen |
EP0695169B1 (fr) | 1993-04-22 | 2002-11-20 | SkyePharma Inc. | Liposomes multivesiculaires de cyclodextrine encapsulant des composes pharmacologiques et leurs procedes d'utilisation |
EP0733122A4 (fr) | 1993-05-26 | 1998-06-10 | Us Health | Proteines de fusion contenant une proteine rep de virus associe a l'adenovirus et proteine bacterienne |
FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
EP0705344B8 (fr) | 1993-06-24 | 2006-05-10 | Advec Inc. | Vecteurs a base d'adenovirus destines a la therapie genique |
DK0667912T3 (da) | 1993-07-13 | 2008-11-10 | Centelion | Defekte adenovirusvektorer og anvendelse heraf i genterapi |
CA2167706A1 (fr) | 1993-07-27 | 1995-02-09 | Nigel Fraser | Vecteurs viraux modifies de l¨adn et leur emploi |
US5631236A (en) | 1993-08-26 | 1997-05-20 | Baylor College Of Medicine | Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
US5362865A (en) | 1993-09-02 | 1994-11-08 | Monsanto Company | Enhanced expression in plants using non-translated leader sequences |
ES2328424T3 (es) | 1993-09-15 | 2009-11-12 | Novartis Vaccines And Diagnostics, Inc. | Vectores de alfavirus recombinantes. |
FR2710536B1 (fr) | 1993-09-29 | 1995-12-22 | Transgene Sa | Usage anti-cancéreux d'un vecteur viral comportant un gène modulateur de la réponse immunitaire et/ou inflammatoire. |
JPH09505561A (ja) | 1993-10-01 | 1997-06-03 | アメリカ合衆国 | 神経系の遺伝子治療 |
DE69434594T2 (de) | 1993-10-25 | 2006-09-21 | Canji, Inc., San Diego | Rekombinante adenoviren-vektor und verfahren zur verwendung |
US5693506A (en) | 1993-11-16 | 1997-12-02 | The Regents Of The University Of California | Process for protein production in plants |
FR2712603B1 (fr) | 1993-11-18 | 1996-02-09 | Centre Nat Rech Scient | Virus recombinants, préparation et utilisation en thérapie génique. |
JPH07241786A (ja) | 1994-03-08 | 1995-09-19 | Fanuc Ltd | 産業用ロボットの制御装置 |
US6780406B1 (en) | 1994-03-21 | 2004-08-24 | The Regents Of The University Of Michigan | Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene |
US7252989B1 (en) | 1994-04-04 | 2007-08-07 | Board Of Regents, The University Of Texas System | Adenovirus supervector system |
CA2189067A1 (fr) | 1994-04-28 | 1995-11-09 | Gary J. Nabel | Vecteur d'apport de genes utilisant un adn plasmidique encapsule dans un adenovirus et une lignee cellulaire d'encapsidation |
EP0772689B1 (fr) | 1994-05-09 | 2007-12-19 | Oxford Biomedica (UK) Limited | Vecteurs retroviraux a taux de recombinaison reduit |
DE69535178T2 (de) | 1994-06-10 | 2006-12-14 | Genvec, Inc. | Adenoviren-vektor systeme und zelllinien |
FR2723588B1 (fr) | 1994-08-12 | 1996-09-20 | Rhone Poulenc Rorer Sa | Adenovirus comprenant un gene codant pour la glutathion peroxydase |
IL117483A (en) | 1995-03-17 | 2008-03-20 | Bernard Brodeur | MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K. |
WO1996037626A1 (fr) | 1995-05-22 | 1996-11-28 | Chiron Corporation | Integration de vecteurs de recombinaison dans une position specifique du genome d'un eucaryote, assuree par une proteine chimere du type integrase |
US5753235A (en) | 1996-02-15 | 1998-05-19 | Heska Corporation | Recombinant canine herpesviruses |
EP0934336A1 (fr) * | 1996-05-14 | 1999-08-11 | Smithkline Beecham Corporation | Nouveaux composes |
DE19630390A1 (de) | 1996-07-26 | 1998-01-29 | Chiron Behring Gmbh & Co | Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung |
CA2264012C (fr) | 1996-08-13 | 2011-04-26 | Chiron Corporation | Compositions et procedes d'apport de polynucleotides |
US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
GB9713156D0 (en) | 1997-06-20 | 1997-08-27 | Microbiological Res Authority | Vaccines |
US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
CA2671261A1 (fr) | 1997-11-06 | 1999-05-20 | Novartis Vaccines And Diagnostics S.R.L. | Antigenes de neisseria |
AU762606B2 (en) | 1997-11-21 | 2003-06-26 | Genset S.A. | Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
KR100735653B1 (ko) | 1997-11-28 | 2007-07-06 | 세로노 제네틱스 인스티튜트 에스.에이. | 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
AU753971B2 (en) * | 1997-12-31 | 2002-10-31 | Millennium Pharmaceuticals, Inc. | Essential bacterial genes and their use |
ATE446368T1 (de) | 1998-01-14 | 2009-11-15 | Novartis Vaccines & Diagnostic | Antigene aus neisseria meningitidis |
EP2261355A3 (fr) | 1998-05-01 | 2012-01-11 | Novartis Vaccines and Diagnostics, Inc. | Antigènes de Neisseria meningitidis et compositions |
JP2002531055A (ja) * | 1998-07-27 | 2002-09-24 | マイクロビアル テクニクス リミティッド | 肺炎連鎖球菌のタンパク質及び核酸分子 |
JP2004511201A (ja) | 1998-10-09 | 2004-04-15 | カイロン コーポレイション | ナイセリアゲノム配列およびそれらの使用方法 |
CA2350775A1 (fr) | 1998-11-12 | 2000-05-18 | The Regents Of The University Of California | Sequence genomique de chlamydia pneumoniae |
GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
JP4846906B2 (ja) | 1999-03-19 | 2011-12-28 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
CA2365914A1 (fr) | 1999-04-09 | 2000-10-19 | Techlab, Inc. | Support proteique recombinant de la toxine a du clostridium recombinant pour vaccins conjugues polysaccharides |
IL149472A0 (en) * | 1999-12-30 | 2002-11-10 | Bristol Myers Squibb Co | Nucleotide sequences and polypeptides encoded by the sequences that are essential for bacterial viability and methods for detecting and utilizing the same |
ES2507100T3 (es) | 2000-01-17 | 2014-10-14 | Novartis Vaccines And Diagnostics S.R.L. | Vacuna OMV suplementada contra meningococo |
CA2404260A1 (fr) * | 2000-03-21 | 2001-09-27 | Elitra Pharmaceuticals, Inc. | Identification de genes esentiels dans des procaryotes |
DE60139690D1 (de) | 2000-07-03 | 2009-10-08 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
EP2189473A3 (fr) | 2000-10-27 | 2010-08-11 | Novartis Vaccines and Diagnostics S.r.l. | Acides nucléiques et protéines dérivés des groupes de streptocoques A et B |
GB0107658D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
TWI517268B (zh) | 2009-08-07 | 2016-01-11 | 半導體能源研究所股份有限公司 | 端子構造的製造方法和電子裝置的製造方法 |
-
2001
- 2001-03-27 GB GBGB0107658.7A patent/GB0107658D0/en not_active Ceased
-
2002
- 2002-03-27 AU AU2002309130A patent/AU2002309130A1/en not_active Abandoned
- 2002-03-27 EP EP02735782A patent/EP1373513A2/fr not_active Withdrawn
- 2002-03-27 EP EP10179940A patent/EP2270175A1/fr not_active Withdrawn
- 2002-03-27 EP EP10179935A patent/EP2278009A1/fr not_active Withdrawn
- 2002-03-27 EP EP10179948A patent/EP2270176A1/fr not_active Withdrawn
- 2002-03-27 EP EP10179956A patent/EP2314697A1/fr not_active Withdrawn
- 2002-03-27 EP EP10179966A patent/EP2278010A1/fr not_active Withdrawn
- 2002-03-27 EP EP10179962A patent/EP2270177A1/fr not_active Withdrawn
- 2002-03-27 WO PCT/IB2002/002163 patent/WO2002077021A2/fr not_active Application Discontinuation
- 2002-03-27 EP EP05075713A patent/EP1630230A3/fr not_active Withdrawn
- 2002-03-27 CA CA002439431A patent/CA2439431A1/fr not_active Abandoned
- 2002-03-27 JP JP2002576279A patent/JP2005503119A/ja active Pending
- 2002-03-27 US US10/472,928 patent/US20050020813A1/en not_active Abandoned
- 2002-03-27 EP EP10179925A patent/EP2278008A3/fr not_active Withdrawn
-
2008
- 2008-11-28 JP JP2008303928A patent/JP2009213466A/ja active Pending
-
2010
- 2010-10-05 US US12/897,952 patent/US20120128707A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998018931A2 (fr) * | 1996-10-31 | 1998-05-07 | Human Genome Sciences, Inc. | Polynucleotides et sequences de streptococcus pneumoniae |
WO2000006738A2 (fr) * | 1998-07-27 | 2000-02-10 | Microbial Technics Limited | Acides nucleiques et proteines de streptococcus pneumoniae |
Non-Patent Citations (2)
Title |
---|
CAMARA M ET AL: "A neuraminidase from Streptococcus pneumoniae has the features of a surface protein.", INFECTION AND IMMUNITY, vol. 62, no. 9, 1994, pages 3688 - 3695, XP001118871, ISSN: 0019-9567 * |
TETTELIN HERVE ET AL: "Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.", SCIENCE (WASHINGTON D C), vol. 293, no. 5529, 2001, pages 498 - 506, XP002218261, ISSN: 0036-8075 * |
Also Published As
Publication number | Publication date |
---|---|
EP1630230A3 (fr) | 2006-05-17 |
EP2314697A1 (fr) | 2011-04-27 |
JP2005503119A (ja) | 2005-02-03 |
CA2439431A1 (fr) | 2002-10-03 |
US20050020813A1 (en) | 2005-01-27 |
EP2278008A3 (fr) | 2011-05-25 |
EP2270177A1 (fr) | 2011-01-05 |
EP2278010A1 (fr) | 2011-01-26 |
EP2278009A1 (fr) | 2011-01-26 |
EP2278008A2 (fr) | 2011-01-26 |
US20120128707A1 (en) | 2012-05-24 |
GB0107658D0 (en) | 2001-05-16 |
EP1630230A2 (fr) | 2006-03-01 |
WO2002077021A2 (fr) | 2002-10-03 |
EP1373513A2 (fr) | 2004-01-02 |
JP2009213466A (ja) | 2009-09-24 |
EP2270175A1 (fr) | 2011-01-05 |
EP2270176A1 (fr) | 2011-01-05 |
AU2002309130A1 (en) | 2002-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002077021A3 (fr) | Proteines et acides nucleiques de streptococcus pneumoniae | |
WO2002034771A3 (fr) | Acides nucleiques et proteines derives des groupes de streptocoques a et b | |
WO2003093306A3 (fr) | Acides nucleiques et proteines tires des groupes de streptocoques a et b | |
EP2298796A3 (fr) | Protéines et acides nucléiques de Staphylococcus aureus | |
WO2003052118A3 (fr) | Beta-glucosidase bgl4 et acides nucleiques la codant | |
WO2003052054A3 (fr) | Bgl5 béta-glucosidase et acides nucléiques codant ce dernier | |
WO2003027306A3 (fr) | Beta-glucosidase bgl3 et acides nucleiques la codant | |
WO1999057280A3 (fr) | Compositions et antigenes a base de meningocoque | |
WO2003054511A3 (fr) | Procedes de quantification d'acides nucleiques au moyen de reactions couplees d'amplification et de ligation | |
AU2001241414A1 (en) | Nucleic acids, proteins, and antibodies | |
WO1999036544A3 (fr) | Antigenes du $i(neisseria meningitidis) | |
WO2002079241A3 (fr) | Proteines | |
WO2003048309A3 (fr) | Polymerases d'acides nucleiques provenant de thermus thermophilus | |
WO2005013904A3 (fr) | Acides nucleiques, proteines, vaccins contre le sras et leurs utilisations | |
WO2002066650A3 (fr) | Polypeptides de streptococcus pyogenes et fragments d'adn correspondants | |
AU2001282084A1 (en) | Nucleotide sequences which code for the sigh gene | |
AU2002337248A1 (en) | Nucleic acids coding for novel fbox proteins, their diagnostic and therapeutic uses | |
AU2001272533A1 (en) | Nucleotide sequence which codes for the alr gene | |
WO2001057187A3 (fr) | Nouveaux acides nucleiques et polypeptides medullaires | |
WO2003014374A3 (fr) | $g(g)-carboxylase de l'espece conus | |
WO2003072800A3 (fr) | Proteines d'adherence a et de penetration dans haemophilus | |
WO2001088091A3 (fr) | Nouveaux acides nucleiques et polypeptides de moelle osseuse | |
AU2002250943A1 (en) | Signal transduction proteins 15b3, 15b3-1 and 15b3-2, and related dna sequences | |
AU2002331828A1 (en) | Polymerases, nucleic acids encoding them and methods for making and using them | |
AU2002304780A1 (en) | Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2439431 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002576279 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002735782 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002735782 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10472928 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002735782 Country of ref document: EP |